HKMPY Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Hikma Pharmaceuticals PLC

Watchlist Manager

Watchlist

Price: 41.31 USD

Market Cap: $4.6B

H	Hikma Pharmaceuticals PLC OTC:HKMPY	UK

Profitability Summary

Hikma Pharmaceuticals PLC's profitability score is 57/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

44%

Sustainable 3Y Average Gross Margin

46%

Declining Gross Margin

50% > 44%

Healthy Operating Margin

21%

Sustainable 3Y Average Operating Margin

21%

Declining Operating Margin

23% > 21%

Healthy Net Margin

14%

Sustainable 3Y Average Net Margin

11%

Net Margin is Increasing

5% > 14%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

14% > 6%

Positive ROE

18%

Positive 3Y Average ROE

Positive 3Y Average ROIC

12%

ROIC is Increasing

10% > 12%

View All

Hide

Collapse

57 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.